We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

74 hedge funds and large institutions have $485M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less funds holding

Funds holding: 81 → 74 (-7)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

46% less capital invested

Capital invested by funds: $895M → $485M (-$410M)

Holders
74
Holders Change
-7
Holders Change %
-8.64%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
26
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$45.8M
2
VC
Vivo Capital
California
+$18.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$11.1M
4
WP
Woodline Partners
California
+$5.51M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.14M

Top Sellers

Rank Fund Capital Flow
1
ECM
Element Capital Management
New York
-$13.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.8M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.9M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.79M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
EMG
51
Ellington Management Group
Connecticut
$162K +$248K +2,150 New
Geode Capital Management
52
Geode Capital Management
Massachusetts
$149K +$229K +1,988 New
Squarepoint
53
Squarepoint
New York
$137K +$76.7K +666 +58%
M&T Bank
54
M&T Bank
New York
$133K +$27.8K +241 +16%
Mitsubishi UFJ Asset Management
55
Mitsubishi UFJ Asset Management
Japan
$128K +$38.6K +335 +25%
WCM
56
Weld Capital Management
New York
$103K -$227K -1,973 -59%
EGM
57
Engineers Gate Manager
New York
$98K +$150K +1,300 New
Citigroup
58
Citigroup
New York
$97K +$114K +991 +328%
IAA
59
Ironsides Asset Advisors
North Carolina
$88K +$135K +1,175 New
Legal & General Group
60
Legal & General Group
United Kingdom
$87K +$39.4K +342 +42%
Zurich Cantonal Bank
61
Zurich Cantonal Bank
Switzerland
$85K – – –
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$84K – – –
PNC Financial Services Group
63
PNC Financial Services Group
Pennsylvania
$76K +$5.3K +46 +5%
Morgan Stanley
64
Morgan Stanley
New York
$49K +$7.95K +69 +12%
PFO
65
Pathstone Family Office
New Jersey
$33K +$50.7K +440 New
SFS
66
Sowell Financial Services
Arkansas
$31K +$48K +417 New
UBS Group
67
UBS Group
Switzerland
$29K -$4.26K -37 -9%
Barclays
68
Barclays
United Kingdom
$16K -$2.07K -18 -8%
APA
69
American Portfolios Advisors
New York
$8.47K – – –
Wells Fargo
70
Wells Fargo
California
$5K +$3.57K +31 +79%
Daiwa Securities Group
71
Daiwa Securities Group
Japan
$2K +$1.04K +9 +41%
OPS
72
Orion Portfolio Solutions
Nebraska
$2K +$2.88K +25 New
MAWCM
73
Mine & Arao Wealth Creation & Management
California
$1K – – –
Osaic Holdings
74
Osaic Holdings
Arizona
$1K +$921 +8 New
ECM
75
Element Capital Management
New York
– -$13.4M -97,162 Closed
1 2
3
4

ORTX Hedge Fund Activity: Q1 2020 in Review

74 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2020, worth a combined $485M — down 46% from $895M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ORTX and 13 opened new positions — a net loss of 6 holders — while 22 trimmed existing stakes and 26 added.

The largest buyer was RA Capital Management, adding an estimated $45.8M. The largest seller was Element Capital Management, exiting entirely with an estimated $13.4M sold.

  • 74 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2020, down from 81 in Q4 2019.
  • Funds reported $485M of Orchard Therapeutics plc American Depositary Shares stock for Q1 2020, down 46% quarter-over-quarter.
  • 13 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2020 and 19 closed out, a net change of -6 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q1 2020 was RA Capital Management, an estimated $45.8M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2020 was Element Capital Management, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2020.